Trials
Search / Trial NCT05652582

Seroprevalence of Covid-19 in the Staff of the University Hospitals of Strasbourg

Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Dec 13, 2022

Apply for Trial

Trial Information

Current as of January 13, 2025

Completed

Keywords

Covid 19 Sars Cov 2 Prevalence Of Sars Co V 2

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion criteria:
  • • Adult subject (≥ 18 years of age)
  • • Hospital staff practicing at HUS who performed SARS-CoV 2 serology in the period from 06/22/2020 to 11/1/2020
  • Exclusion criteria:
  • • - Subject not meeting inclusion criteria

About University Hospital, Strasbourg, France

The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.

Locations

Strasbourg, , France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials